EUVIMEDEUVIMED entdecken
Crossref

Extensive red blood cell matching considering patient alloimmunization risk

Merel L Wemelsfelder iD, Ronald H G van de Weem iD, Jessie S Luken iD, Masja de Haas iD, René W L M Niessen, C Ellen van der Schoot iD, Han Hoogeveen iD, Folarin B Oyebolu iD, Dick den Hertog iD, Mart P Janssen iD

Vox Sanguinis · 2024

DOI: 10.1111/vox.13594 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vox Sanguinis, 2024. Verfasst von Merel L Wemelsfelder und 9 weiteren Autor:innen. Beteiligte Einrichtung: Donor Medicine Research Department, Sanquin Research, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Erythrocytes, Blood Group Antigens. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Stichting Sanquin Bloedvoorziening, NIHR Artificial Intelligence in Health and Care Award, NIHR BTRU in Donor Health and Behaviour.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Red blood cell (RBC) transfusions pose a risk of alloantibody development in patients. For patients with increased alloimmunization risk, extended preventive matching is advised, encompassing not only the ABO‐D blood groups but also the most clinically relevant minor antigens: C, c, E, e, K, Fy a , Fy b , Jk a , Jk b , S and s. This study incorporates patient‐specific data and the clinical consequences of mismatching into the allocation process. Materials and Methods We have redefined the MINimize Relative Alloimmunization Risks (MINRAR) model to include patient group preferences in selecting RBC units from a finite supply. A linear optimization approach was employed, considering both antigen immunogenicity and the clinical impact of mismatches for specific patient groups. We also explore the advantages of informing the blood bank about scheduled transfusions, allowing for a more strategic blood distribution. The model is evaluated using historical data from two Dutch hospitals, measuring shortages and minor antigen mismatches.

Results

The updated model, emphasizing patient group‐specific considerations, achieves a similar number of mismatches as the original, yet shifts mismatches among patient groups and antigens, reducing expected alloimmunization consequences. Simultaneous matching for multiple hospitals at the distribution centre level, considering scheduled demands, led to a 30% decrease in mismatches and a 92% reduction in shortages.

Conclusion

The reduction of expected alloimmunization consequences by incorporating patient group preferences demonstrates our strategy's effectiveness for patient health. Substantial reductions in mismatches and shortages with multi‐hospital collaboration highlights the importance of sharing information in the blood supply chain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythrocytesBlood Group AntigensHumansBlood TransfusionErythrocyte TransfusionBlood Group IncompatibilityBlood Grouping and CrossmatchingIsoantibodiesABO Blood-Group System

Stichwörter der Autor:innen

RBC matchingextensive antigen typinglinear optimizationsupply chain

Substanzen

IsoantibodiesABO Blood-Group SystemBlood Group Antigens

Autor:innen und Institutionen

  • Donor Medicine Research Department, Sanquin Research, Amsterdam, the Netherlands.
  • Business Analytics Department, University of Amsterdam, Amsterdam, the Netherlands.
  • Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, the Netherlands.
  • Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands.
  • Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.
  • OLVG Laboratory BV, Amsterdam, the Netherlands.

ORCID-Profile: Merel L Wemelsfelder, Ronald H G van de Weem, Jessie S Luken, Masja de Haas, C Ellen van der Schoot, Han Hoogeveen, Folarin B Oyebolu, Dick den Hertog, Mart P Janssen

Förderung

  • Stichting Sanquin Bloedvoorziening
  • NIHR Artificial Intelligence in Health and Care Award
  • NIHR BTRU in Donor Health and Behaviour
  • NIHR Cambridge BRC
  • NIHR Cambridge Biomedical Research Centre

Zitieren

APA

Wemelsfelder, M. L., van de Weem, R. H. G., Luken, J. S., de Haas, M., Niessen, R. W. L. M., van der Schoot, C. E., Hoogeveen, H., Oyebolu, F. B., den Hertog, D., & Janssen, M. P. (2024). Extensive red blood cell matching considering patient alloimmunization risk. Vox Sanguinis. https://doi.org/10.1111/vox.13594

Vancouver

Wemelsfelder ML, van de Weem RHG, Luken JS, de Haas M, Niessen RWLM, van der Schoot CE, et al. Extensive red blood cell matching considering patient alloimmunization risk. Vox Sanguinis. 2024. doi:10.1111/vox.13594

BibTeX
@article{Wemelsfelder2024,
  author = {Wemelsfelder, Merel L and van de Weem, Ronald H G and Luken, Jessie S and de Haas, Masja and Niessen, René W L M and van der Schoot, C Ellen and Hoogeveen, Han and Oyebolu, Folarin B and den Hertog, Dick and Janssen, Mart P},
  title = {Extensive red blood cell matching considering patient alloimmunization risk},
  journal = {Vox Sanguinis},
  year = {2024},
  doi = {10.1111/vox.13594}
}
Kostenlos starten →